HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The effect of prednisone in the development of nephropathy in Schoenlein-Henoch purpura].

Abstract
The authors hospitalized in 1976-1987 39 children with Schönlein-Henoch's purpura who on admission had a normal finding in urine. Of the above patients 28 were given prednisone already at the onset of hospitalization, to 11 prednisone was not administered. Patients with prednisone developed nephropathy in one instance (3.5%), patients without prednisone 6 times (54.5%) which is a significant difference. The average prednisone dose was 1.7 mg per kg body weight per day for an average period of 21 days. Usually for 6-10 days the same dose was administered and then it was gradually reduced.
AuthorsJ Buchanec, V Galanda, S Beláková, M Minárik, M Zibolen
JournalCeskoslovenska pediatrie (Cesk Pediatr) Vol. 44 Issue 3 Pg. 145-6 (Mar 1989) ISSN: 0069-2328 [Print] Czech Republic
Vernacular TitleOvplyvnenie vzniku nefropatie pri Schönleinovej-Henochovej purpure prednisonom.
PMID2731281 (Publication Type: Journal Article)
Chemical References
  • Prednisone
Topics
  • Child
  • Humans
  • IgA Vasculitis (complications, drug therapy)
  • Kidney Diseases (etiology, prevention & control)
  • Prednisone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: